Cargando…
Population-based study of “no evident disease activity” in MS
OBJECTIVE: To determine the persistence of no evident disease activity (NEDA) in a population-based relapsing-remitting MS (RRMS) cohort. METHODS: All incident cases of RRMS in Olmsted County between 2000 and 2011 were identified using a medical records linkage system. Persistence of NEDA after RRMS...
Autores principales: | Parks, Natalie E., Pittock, Sean J., Mandrekar, Jay, Kantarci, Orhun H., Lucchinetti, Claudia F., Weinshenker, Brian G., Keegan, B. Mark, Tobin, W. Oliver, Tillema, Jan-Mendelt, Toledano, Michel, Flanagan, Eoin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134213/ https://www.ncbi.nlm.nih.gov/pubmed/30211251 http://dx.doi.org/10.1212/NXI.0000000000000495 |
Ejemplares similares
-
Cervical spinal cord atrophy: An early marker of progressive MS onset
por: Zeydan, Burcu, et al.
Publicado: (2018) -
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020) -
CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2021) -
Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients
por: Fereidan‐Esfahani, Mahboubeh, et al.
Publicado: (2023) -
Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology
por: Kalinowska‐Lyszczarz, Alicja, et al.
Publicado: (2023)